| Product NDC: | 0015-3032 |
| Proprietary Name: | CEENU |
| Non Proprietary Name: | LOMUSTINE |
| Active Ingredient(s): | 100 mg/1 & nbsp; LOMUSTINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0015-3032 |
| Labeler Name: | E.R. Squibb & Sons, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017588 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081215 |
| Package NDC: | 0015-3032-20 |
| Package Description: | 1 BOTTLE in 1 CARTON (0015-3032-20) > 20 CAPSULE, GELATIN COATED in 1 BOTTLE |
| NDC Code | 0015-3032-20 |
| Proprietary Name | CEENU |
| Package Description | 1 BOTTLE in 1 CARTON (0015-3032-20) > 20 CAPSULE, GELATIN COATED in 1 BOTTLE |
| Product NDC | 0015-3032 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LOMUSTINE |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20081215 |
| Marketing Category Name | NDA |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | LOMUSTINE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |